Patent · US Active

Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

US8524736B2 · kind B2 · utility

22Cited by
37References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2012
Grant dateSep 3, 2013
Priority date—
Expiry dateFeb 10, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The subject invention provides stereoisomeric compounds of formula (X):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.